Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a vaginal gel for the prevention of pregnancy; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California. Show more

Location: 7770 Regents Rd, San Diego, CA, 92122-1967, United States | Website: https://www.evofem.com | Industry: Biotechnology | Sector: Healthcare

Market Cap

1.424M

52 Wk Range

$0.01 - $0.02

Previous Close

$0.01

Open

$0.01

Volume

632,783

Day Range

$0.01 - $0.01

Enterprise Value

48.91M

Cash

125K

Avg Qtr Burn

-1.307M

Insider Ownership

0.00%

Institutional Own.

0.00%

Qtr Updated

06/30/25

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Phexxi™ Details Birth control	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
EVO100 Details Sexually transmitted infections	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Phexxi™ Details Birth control, Urinary tract infection	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.